Literature DB >> 17591521

An update on pruritus associated with CKD.

Tejesh S Patel1, Barry I Freedman, Gil Yosipovitch.   

Abstract

The prevalence of chronic kidney disease (CKD) and end-stage renal disease is increasing worldwide. Despite improvements in dialysis methods, including the development of novel biocompatible membranes and ultrapure dialysate, CKD-associated pruritus remains a common and significant public health issue. Not only does this distressing symptom profoundly impact on quality of life and sleep, recent evidence showed that pruritus also was associated with poor patient outcome. Nonetheless, nephrologists and other health care professionals often fail to recognize and adequately address the pruritus associated with CKD. The pathophysiological mechanism of CKD-associated pruritus is poorly defined, and, as a result, the development of specific therapies has proved to be a challenge. The purpose of this review is to highlight the importance of this neglected topic by providing an overview of recent epidemiological studies, outcomes data, proposed pathophysiological mechanisms, and emerging treatment options.

Entities:  

Mesh:

Year:  2007        PMID: 17591521     DOI: 10.1053/j.ajkd.2007.03.010

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  30 in total

1.  Medications associated with restless legs syndrome: a case-control study in the US Renal Data System (USRDS).

Authors:  Donald L Bliwise; Rebecca H Zhang; Nancy G Kutner
Journal:  Sleep Med       Date:  2014-06-13       Impact factor: 3.492

Review 2.  Pruritus and renal failure.

Authors:  Timothy G Berger; Martin Steinhoff
Journal:  Semin Cutan Med Surg       Date:  2011-06

3.  Assessment of the psychological burden associated with pruritus in hemodialysis patients using the kidney disease quality of life short form.

Authors:  Gildete Barreto Lopes; Fernanda Conceição Pereira Nogueira; Milena Reis de Souza; Maria Auxiliadora Penalva; Josete Leão de Amorim; Ronald L Pisoni; Bruce M Robinson; Antonio Alberto Lopes
Journal:  Qual Life Res       Date:  2011-07-09       Impact factor: 4.147

Review 4.  New insights into the pathophysiology and treatment of chronic itch in patients with end-stage renal disease, chronic liver disease, and lymphoma.

Authors:  Hui Wang; Gil Yosipovitch
Journal:  Int J Dermatol       Date:  2010-01       Impact factor: 2.736

5.  Skin disorders in peritoneal dialysis patients: An underdiagnosed subject.

Authors:  Meltem Gursu; Sami Uzun; Derya Topcuoğlu; Leyli Kadriye Koc; Lamiye Yucel; Abdullah Sumnu; Egemen Cebeci; Oktay Ozkan; Ahmet Behlul; Leyla Koc; Savas Ozturk; Rumeyza Kazancioglu
Journal:  World J Nephrol       Date:  2016-07-06

Review 6.  Uraemic pruritus: clinical characteristics, pathophysiology and treatment.

Authors:  Lucio Manenti; Pius Tansinda; Augusto Vaglio
Journal:  Drugs       Date:  2009       Impact factor: 9.546

7.  Effects of lanthanum carbonate on vascular calcification in elderly maintenance hemodialysis patients.

Authors:  Xiao-Hui Wang; Xin Zhang; Chang-Jun Mu; Yong He; Qing-Ping Peng; Guo-Sheng Yang; Ming-Mei Li; Duan Liu; Jing Li; Guo-Hua Ding
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2015-07-31

8.  Advanced aging skin and itch: addressing an unmet need.

Authors:  Lilit Garibyan; Albert S Chiou; Sarina B Elmariah
Journal:  Dermatol Ther       Date:  2013 Mar-Apr       Impact factor: 2.851

9.  Voxel-based morphometry and arterial spin labeling fMRI reveal neuropathic and neuroplastic features of brain processing of itch in end-stage renal disease.

Authors:  Alexandru D P Papoiu; Nichole M Emerson; Tejesh S Patel; Robert A Kraft; Rodrigo Valdes-Rodriguez; Leigh A Nattkemper; Robert C Coghill; Gil Yosipovitch
Journal:  J Neurophysiol       Date:  2014-06-18       Impact factor: 2.714

10.  Epidemiology and determinants of pruritus in pre-dialysis chronic kidney disease patients.

Authors:  Berna Solak; Seyyid Bilal Acikgoz; Savas Sipahi; Teoman Erdem
Journal:  Int Urol Nephrol       Date:  2016-01-14       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.